Pharmafile Logo

Olaf Bartsch

- PMLiVE

Insmed claims first FDA okay for limited population antibiotic

Arikayce is cleared to treat lung disease caused by MAC

- PMLiVE

Significant figures

Insmed’s Olaf Bartsch tells PME about the US biotech’s year of progress

Insmed appoints FDA’s Dr Eugene Sullivan

He joinsthe US biopharmaceutical firm as its chief medical officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links